The role of gut dysbiosis-associated inflammation in heart failure

Two Gut Microbiota-Derived Toxins Are Closely Associated with Cardiovascular Diseases: A Review

(2021) Tomoya Yamashita et al.   Toxins

Relação entre Resposta Imune Inata do Receptor Toll-Like-4 (TLR-4) e o Processo Fisiopatológico da Cardiomiopatia da Obesidade

(2021) Pedro Henrique Rizzi Alves et al.   Arquivos Brasileiros de Cardiologia

Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?

(2021) Larissa Salomoni Carpes et al.   PLoS One

Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics

(2020) Jalal Moludi et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Gut microbiota, endotoxemia, inflammation, and oxidative stress in patients with heart failure, left ventricular assist device, and transplant

(2020) Melana Yuzefpolskaya et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases

(2020) Estefania Sanchez-Rodriguez et al.   Nutrients

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

(2020) Ygor Parladore Silva et al.   Frontiers in Endocrinology

Gut dysbiosis and heart failure: navigating the universe within

(2020) Shivank Madan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Factors affecting the composition of the gut microbiota, and its modulation

(2019) Nihal Hasan et al.   PeerJ

Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction

(2018) Pedro Carrera-Bastos et al.   Aging and Disease

Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction

(2018) Xin Zhou et al.   Microbiome

Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases

(2018) Gabriele G. Schiattarella et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors

(2018) Jacobo de la Cuesta-Zuluaga et al.   Nutrients

The gut-blood barrier permeability – A new marker in cardiovascular and metabolic diseases?

(2017) Marcin Ufnal et al.   MEDICAL HYPOTHESES

Microbiome, trimethylamine N-oxide, and cardiometabolic disease

(2017) W.H. Wilson Tang et al.   Translational Research

The Gut and Intestinal Bacteria in Chronic Heart Failure

(2009) Anja Sandek et al.   CURRENT DRUG METABOLISM